Femasys is trading 6.18% up at $2.75 in after-hours trading after rising from the September 18 regular-session close of $2.59; available coverage does not establish a clear catalyst.
- No major company-specific announcement dated September 18 was identified.
- Minnesota Womenβs Care adopted Femasysβ fertility portfolio on September 15, but the news predates the move and does not directly explain it.
- Broader market gains were modest, leaving the catalyst unclear.